Biblio Discovery — Demo Discovery Service

9 hasil untuk "Chang-Ching Lin"

Menampilkan 1–9 · 0,36 detik · RSS

  1. Bab Buku Teks lengkap

    Intelligent Vibration Signal Diagnostic System Using Artificial Neural Network

    Chang-Ching Lin

    Artificial Neural Networks - Industrial and Control Engineering Applications · 2011 · Inggris · IntechOpen

  2. Artikel Jurnal Teks lengkap

    Rank-Based Comparative Research Flow Benchmarking the Effectiveness of AHP–GTMA on Aiding Decisions of Shredder Selection by Reference to AHP–TOPSIS

    Zheng-Yun Zhuang; Chang-Ching Lin; Chih-Yung Chen dkk.

    Applied Sciences, Vol. 8 No. 10 · 2018 · Inggris · DOAJ Scopus

    The AHP–GTMA (analytic hierarchy process and graph theory and matrix approach) has been applied to select the best paper shredder before a company was making a bulk purchase order. However, there is a question as to whether one such relatively recent approach is effective to aid the selection…

  3. Artikel Jurnal Teks lengkap

    Design of a Compact Multiband Monopole Antenna with MIMO Mutual Coupling Reduction

    Chang-Keng Lin; Ding-Bing Lin; Han-Chang Lin dkk.

    Sensors, Vol. 24 No. 17 · 2024 · Inggris · DOAJ Scopus

    In this article, the authors present the design of a compact multiband monopole antenna measuring 30 × 10 × 1.6 mm3, which is aimed at optimizing performance across various communication bands, with a particular focus on Wi-Fi and sub-6G bands. These bands include the 2.4 GHz band, the 3.5 GHz…

  4. Artikel Jurnal Teks lengkap

    Study of Out-Of-Hospital Access to HIS System: A Security Perspective

    Chih-Yung Chen; Yi-Chang Hsu; Chang-Ching Lin dkk.

    Sensors, Vol. 19 No. 11 · 2019 · Inggris · DOAJ Scopus

    In light of the need for Extramural Hospital Information System (HIS) access through mobile devices outside the hospital, this research analyzes situational information security threats, including the circumstances in which a mobile device may get lost and personal data may be stolen. Moreover, the…

  5. Artikel Jurnal

    Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer

    Kyung-min Lee; Angel L. Guerrero-Zotano; Alberto Servetto dkk.

    Nature Communications, Vol. 11 No. 1 · 2020 · Inggris · DOAJ Scopus

    The 17q23 amplicon is associated with poor outcome in ER+ breast cancers, but the causal genes responsible endocrine resistance in this region are unclear. In this study, the authors demonstrate that PRR11 located at 17q23, is critical for conferring endocrine resistance through activation of PI3K…

  6. Artikel Jurnal Teks lengkap

    R26R-GR : A Cre-Activable Dual Fluorescent Protein Reporter Mouse

    You-Tzung Chen; Ming-Shian Tsai; Tsung-Lin Yang dkk.

    Public Library of Science · 2012 · Inggris · PLOS Scopus

    Green fluorescent protein (GFP) and its derivatives are the most widely used molecular reporters for live cell imagining. The development of organelle-specific fusion fluorescent proteins improves the labeling resolution to a higher level. Here we generate a R26 dual fluorescent protein reporter…

    Juga tersedia di: DOAJ

  7. Artikel Jurnal

    PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

    Chang-Ching Lin; Tsung-Cheng Chang; Yunguan Wang dkk.

    Nature Communications, Vol. 15 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract CDK4/6 inhibitors (CDK4/6i) have improved survival of patients with estrogen receptor-positive (ER+) breast cancer. However, patients treated with CDK4/6i eventually develop drug resistance and progress. RB1 loss-of-function alterations confer resistance to CDK4/6i, but the optimal therapy…

  8. Artikel Jurnal

    A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancerResearch in context

    Maxwell R. Lloyd; Rosario Chica-Parrado; Caroline M. Weipert dkk.

    EBioMedicine, Vol. 118 · 2025 · Inggris · DOAJ Scopus

    Summary: Background: CDK4/6 inhibitors (CDK4/6i) are used for management of hormone receptor-positive (HR+) metastatic breast cancer (MBC), and activation of the RAS/MAPK and PI3K/AKT signalling pathways has been implicated in resistance to these agents. Pathogenic NF1 mutations (pNF1m) dysregulate…